Title:
免疫誘導剤
Document Type and Number:
Japanese Patent JP7181676
Kind Code:
B2
Abstract:
An object of the present invention is to discover a novel peptide useful as an active ingredient in an agent for treating or preventing cancer, and to provide the use of the polypeptide as an immune inducer. The immune inducer containing as an active ingredient: (a) a polypeptide consisting of any one of the amino acid sequences represented by SEQ ID NOs: 35 to 67; or (b) a polypeptide comprising one to several amino acid deletions, substitutions and/or additions in the amino acid sequence of the polypeptide (a); is useful as an agent for treating or preventing cancer, etc.
Inventors:
Sho Kurihara
Fumiyoshi Okano
Fumiyoshi Okano
Application Number:
JP2016555386A
Publication Date:
December 01, 2022
Filing Date:
August 05, 2016
Export Citation:
Assignee:
TORAY INDUSTRIES,INC.
International Classes:
A61K39/00; A61K48/00; A61P35/00; A61P35/02; A61P37/04; C07K7/06; C07K7/08; C07K14/475; C12N5/078; C12N5/0783
Domestic Patent References:
| JP2010533735A |
Foreign References:
| WO2011027807A1 | ||||
| US20040248218 | ||||
| WO1997009065A1 |
Other References:
KUMAR D.et al.,SCC-112,a novel cell cycle-regulated molecule,exhibits reduced expression in human renal carcinoma,Gene,2004年,Vol.328,pages 187 to 196,ISSN:0378-1119
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office